Viewing Study NCT03490994


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-25 @ 11:50 PM
Study NCT ID: NCT03490994
Status: UNKNOWN
Last Update Posted: 2019-01-10
First Post: 2018-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)
Sponsor: Yonsei University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module